Literature DB >> 21983076

Biphasic stress response in the soleus during reloading after hind limb unloading.

John M Lawler1, Hyo-Bum Kwak, Jong-Hee Kim, Yang Lee, Jeffrey M Hord, Daniel A Martinez.   

Abstract

INTRODUCTION: Extreme disuse and spaceflight elicit rapid skeletal muscle atrophy, accompanied by elevated proinflammatory signaling and impaired stress response proteins (e.g., heat shock proteins (HSP), insulin-like growth factor 1 (IGF-1)). Recovery of muscle mass is delayed during the early stage of reloading after prolonged unloading, with a concomitant impairment of HSP70 and IGF-1. We postulated that proinflammatory signaling and stress response alterations would characterize early and late phases of signaling during reloading.
METHODS: Twenty-four adult SD rats were divided into the following groups: controls, 28 d of hind limb unloading (HU), HU + early (7 d) reloading (HU-R7), and HU + late (28 d) reloading (HU-R28).
RESULTS: Soleus mass decreased (-55%) with HU and remained depressed (-41%) at HU-R7. Nuclear factor κB activation and oxidative stress were elevated with HU and remained high during reloading. HU elevated inducible nitric oxide synthase and returned to baseline during reloading, whereas 3-nitrotyrosine did not increase with HU and peaked at HU-R7. HU depressed levels of HSP25 phosphorylation at Ser82 and IGF-1. Although p-HSP25 and Akt phosphorylation (Ser473) recovered during early reloading, HSP70, heat shock factor 1, and IGF-1 remained depressed. HSP70, heat shock factor 1, and IGF-1 recovered, whereas p-Akt and 3-nitrotyrosine decreased to control levels at HU-R28.
CONCLUSIONS: Reloading elicited an early phase characterized by elevated nuclear factor κB activation, 3-nitrotyrosine, p-HSP25, and p-Akt levels and a delayed phase with recovery of HSP70, IGF-1, and muscle mass. We conclude that the reloading phenotype in skeletal muscle is expressed in two distinct phases related to (a) pro-inflammatory signaling and (b) muscle mass recovery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21983076     DOI: 10.1249/MSS.0b013e31823ab37a

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  6 in total

1.  Epigallocatechin-3-gallate improves plantaris muscle recovery after disuse in aged rats.

Authors:  Stephen E Alway; Brian T Bennett; Joseph C Wilson; Neile K Edens; Suzette L Pereira
Journal:  Exp Gerontol       Date:  2013-12-03       Impact factor: 4.032

2.  Lifelong wheel running exercise and mild caloric restriction attenuate nuclear EndoG in the aging plantaris muscle.

Authors:  Jong-Hee Kim; Yang Lee; Hyo-Bum Kwak; John M Lawler
Journal:  Exp Gerontol       Date:  2015-06-06       Impact factor: 4.032

3.  EUK-134 ameliorates nNOSμ translocation and skeletal muscle fiber atrophy during short-term mechanical unloading.

Authors:  John M Lawler; Mary Kunst; Jeff M Hord; Yang Lee; Kumar Joshi; Rachel E Botchlett; Angelo Ramirez; Daniel A Martinez
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-29       Impact factor: 3.619

4.  Mature IGF-I excels in promoting functional muscle recovery from disuse atrophy compared with pro-IGF-IA.

Authors:  Soohyun Park; Becky K Brisson; Min Liu; Janelle M Spinazzola; Elisabeth R Barton
Journal:  J Appl Physiol (1985)       Date:  2013-12-26

5.  Paracrine effects of IGF-1 overexpression on the functional decline due to skeletal muscle disuse: molecular and functional evaluation in hindlimb unloaded MLC/mIgf-1 transgenic mice.

Authors:  Sabata Pierno; Giulia M Camerino; Maria Cannone; Antonella Liantonio; Michela De Bellis; Claudio Digennaro; Gianluca Gramegna; Annamaria De Luca; Elena Germinario; Daniela Danieli-Betto; Romeo Betto; Gabriella Dobrowolny; Emanuele Rizzuto; Antonio Musarò; Jean-François Desaphy; Diana Conte Camerino
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

Review 6.  Skeletal Muscle Recovery from Disuse Atrophy: Protein Turnover Signaling and Strategies for Accelerating Muscle Regrowth.

Authors:  Timur M Mirzoev
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.